Drug research

RAP-219

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal SeizuresNCT07594119	RAPP	Phase 3	Recruiting	2029-07Estimated
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Bipolar I DisorderNCT07046494	RAPP	Phase 2	Active not recruiting	2026-08-05Actual
A Long-term Study of the Safety and Effectiveness of RAP-219 in Adults With Focal Onset SeizuresNCT07219407	RAPP	Phase 2	Recruiting	2028-02-03Estimated
Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal EpilepsyNCT06377930	RAPP	Phase 2	Completed	2025-09-26Actual
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1NCT07563881	RAPP	Phase 3	Recruiting	2029-07Estimated

RAPPRecruitingPrimary completion: 2029-07 · Estimated

Trial details

RAPPActive not recruitingPrimary completion: 2026-08-05 · Actual

Trial details

RAPPRecruitingPrimary completion: 2028-02-03 · Estimated

Trial details

RAPPCompletedPrimary completion: 2025-09-26 · Actual

Trial details

RAPPRecruitingPrimary completion: 2029-07 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.